← Open Payments lookup

RAJENDRA GAJULA: Open Payments

NPI 1124011614 · DALLAS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,965 in 51 payments from 12 companies in 2025. Trend: 2023 $7,715 · 2024 $1,611 · 2025 $1,965

Food & beverage: $1,886Education: $80
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$489
Teva Pharmaceuticals USA, Inc.10$405
E.R. Squibb & Sons, L.L.C.8$343
Janssen Pharmaceuticals, Inc3$215
JAZZ PHARMACEUTICALS INC.1$123
Biogen, Inc.1$120
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$110
Vanda Pharmaceuticals Inc.2$63
ABBVIE INC.2$41
Indivior Inc.1$24

Products named: COBENFY, ABILIFY MAINTENA, INVEGA SUSTENNA, UZEDY, REXULTI, AUSTEDO XR, XYWAV, ZURZUVAE.

Industry payments across PA — which companies pay providers there.